A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV
- Status
- COMPLETED
- Phase
- PHASE2
Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2